Roger Paredes, MD, PhD

Roger Paredes, MD, PhD, is a HIV Physician at Hospital Germans Trias i Pujol and Head of the Microbial Genomics Group at the IrsiCaixa AIDS Research Institute, Badalona, Catalonia, Spain.

Roger Paredes obtained an MD, PhD degree in Medicine and Surgery from the Autonomous University of Barcelona (UAB). He specialised in HIV resistance at the Brigham & Women’s Hospital in Boston and Harvard Medical School. His team has demonstrated the clinical utility of HIV-1 deep sequencing in both high- and low-income countries. Dr. Paredes is member of the WHO HIV Drug Resistance Strategy (ResNet) Steering Committee and the International Antiviral Society-USA, which annually produces the IAS-USA list of HIV-1 drug resistance mutations, used worldwide. He is co-author of the Rega algorithm for HIV resistance interpretation and virologist for the EuroSIDA European cohort. His group is presently leading pioneering research into the role of the gut microbiome in the pathogenesis of HIV infection and chronic inflammation. They were the first to describe a link between sexual practices and the fecal microbiome composition. Dr. Paredes combines his research work at irsiCaixa with a senior medical appointment at the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona, Catalonia, Spain.